Many commercial health plans and employer-sponsored benefit programs either exclude anti-obesity medications from formularies entirely or place them on higher cost-sharing tiers, resulting in limited or no insurance coverage for patients, even when clinically appropriate
2026 is the year in which the long-term themes, the true drivers of sustainable success for the burgeoning landscape of obesity treatment, prescription medicines and beyond, become apparent
Human data are often associative rather than interventional, assays lack standardization, and receptor mechanisms may be incomplete or contested
Can supplements enhance the long-term efficacy of GLP-1 medications
Contact Novo Nordisk at 1-800-727-6500 for more information
Mol Psychiatry (2013) 18:2701.10.1038/mp.2012.22 104 SurenPRothCBresnahanMHaugenMHornigMHirtzDet alAssociation between maternal use of folic acid supplements and risk of autism spectrum disorders in children